{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["15(1)"],"submitter":["Gras E"],"pubmed_abstract":["Improving prevention and treatment strategies for invasive fungal infections (IFI) is essential to reduce associated morbidity and mortality. We performed a systematic review and meta-analyses to assess factors associated with IFI in adult patients with hematological malignancies and/or hematopoietic stem cell transplantation (HSCT). We searched PubMed, Embase, CENTRAL and the grey literature from 01/01/2002 to 08/02/2024. Eligible studies were case-control or cohort studies including adult patients with hematological malignancies and/or HSCT and reporting risk factors for IFI. Adult patients with hematological malignancies and/or HSCT. Assessment of risk of bias. Risk of bias assessment was assessed independently using the Critical Appraisal Skills Programme checklists for cohort studies "],"journal":["Scientific reports"],"pagination":["30724"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12371109"],"repository":["biostudies-literature"],"pubmed_title":["Risk factors for invasive fungal infections in adult patients with hematological malignancies and/or stem cell transplant: a systematic review and meta-analysis."],"pmcid":["PMC12371109"],"pubmed_authors":["Monzo-Gallo P","Guitard J","Azoyan L","Lanternier F","Lacombe K","Dechartres A","Surgers L","Brissot E","Gras E","Garcia-Vidal C"],"additional_accession":[]},"is_claimable":false,"name":"Risk factors for invasive fungal infections in adult patients with hematological malignancies and/or stem cell transplant: a systematic review and meta-analysis.","description":"Improving prevention and treatment strategies for invasive fungal infections (IFI) is essential to reduce associated morbidity and mortality. We performed a systematic review and meta-analyses to assess factors associated with IFI in adult patients with hematological malignancies and/or hematopoietic stem cell transplantation (HSCT). We searched PubMed, Embase, CENTRAL and the grey literature from 01/01/2002 to 08/02/2024. Eligible studies were case-control or cohort studies including adult patients with hematological malignancies and/or HSCT and reporting risk factors for IFI. Adult patients with hematological malignancies and/or HSCT. Assessment of risk of bias. Risk of bias assessment was assessed independently using the Critical Appraisal Skills Programme checklists for cohort studies ","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Aug","modification":"2026-05-08T06:50:47.716Z","creation":"2026-04-07T23:30:51.804Z"},"accession":"S-EPMC12371109","cross_references":{"pubmed":["40841820"],"doi":["10.1038/s41598-025-16066-6"]}}